Richard J. Berman Sells 20,000 Shares of CryoPort Inc (CYRX) Stock

CryoPort Inc (NASDAQ:CYRX) CEO Richard J. Berman sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 15th. The shares were sold at an average price of $12.81, for a total value of $256,200.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Shares of CYRX stock opened at $12.42 on Friday. CryoPort Inc has a 1-year low of $6.02 and a 1-year high of $16.88. The firm has a market cap of $435.97 million, a P/E ratio of -36.53 and a beta of 0.85.

CryoPort (NASDAQ:CYRX) last announced its quarterly earnings data on Thursday, August 9th. The consumer goods maker reported ($0.09) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.02). CryoPort had a negative return on equity of 45.60% and a negative net margin of 62.80%. The business had revenue of $4.63 million for the quarter, compared to analyst estimates of $4.36 million. The firm’s revenue was up 58.6% compared to the same quarter last year. analysts expect that CryoPort Inc will post -0.29 EPS for the current fiscal year.

CYRX has been the topic of a number of recent analyst reports. BidaskClub raised CryoPort from a “hold” rating to a “buy” rating in a report on Friday, May 25th. ValuEngine raised CryoPort from a “buy” rating to a “strong-buy” rating in a report on Wednesday, May 2nd. Cowen upped their price objective on CryoPort from $11.00 to $16.00 and gave the stock an “outperform” rating in a report on Monday. Needham & Company LLC upped their price objective on CryoPort from $11.00 to $19.00 and gave the stock a “buy” rating in a report on Monday, July 2nd. Finally, Roth Capital upped their price objective on CryoPort from $12.50 to $22.00 and gave the stock a “buy” rating in a report on Friday, June 29th. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. CryoPort has an average rating of “Buy” and an average target price of $17.25.

A number of hedge funds have recently made changes to their positions in the stock. Creative Planning grew its holdings in CryoPort by 0.8% during the second quarter. Creative Planning now owns 603,540 shares of the consumer goods maker’s stock worth $9,524,000 after acquiring an additional 4,860 shares during the period. D.A. Davidson & CO. grew its holdings in CryoPort by 3.7% during the second quarter. D.A. Davidson & CO. now owns 163,260 shares of the consumer goods maker’s stock worth $2,576,000 after acquiring an additional 5,860 shares during the period. Wells Fargo & Company MN grew its holdings in CryoPort by 14.5% during the first quarter. Wells Fargo & Company MN now owns 53,990 shares of the consumer goods maker’s stock worth $464,000 after acquiring an additional 6,855 shares during the period. Strs Ohio acquired a new stake in CryoPort in the second quarter valued at $115,000. Finally, Metropolitan Life Insurance Co. NY acquired a new stake in CryoPort in the second quarter valued at $136,000. 39.87% of the stock is currently owned by hedge funds and other institutional investors.

CryoPort Company Profile

Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.

Recommended Story: Market Capitalization, Large-Caps, Mid-Caps, Small-Caps

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply